Significant UK Moderna partnership

UK cements 10-year-partnership with Moderna in major boost for vaccines and research

https://www.gov.uk/government/news/uk-cements-10-year-partnership-with-moderna-in-major-boost-for-vaccines-and-research

https://www.gov.uk/government/news/moderna-to-open-vaccine-research-and-manufacturing-centre-in-uk

Moderna to invest in mRNA research and development (R&D) in the UK,

and build a state-of-the-art vaccine manufacturing centre,

with the ability to produce up to 250 million vaccines a year

Suggested advantages

NHS patients will have access to a UK-made supply of COVID-19 jabs,

as well as cutting-edge vaccines developed for other respiratory diseases,

such as flu and respiratory syncytial virus (RSV)

Create more than 150 jobs

Further future-proof the UK against potential pandemics,

speedy access to the latest advancements in vaccine technology

UK cements its status as a life sciences superpower.

The partnership with Moderna

UK Health Security Agency (UKHSA) working with Moderna,

to ensure early vaccine development,

supporting the G7 mission to get from variant to vaccine in 100 days.

NHS patients access to Moderna’s COVID-19 vaccines,

that can protect against multiple variants.

This is the finalisation of the partnership,

led by the Vaccine Taskforce.

Secretary of State for Health and Social Care, Steve Barclay

It is vital we invest in fighting future variants of this disease, (covid),

as well as other deadly viruses that are circulating,

such as seasonal flu and RSV,

and this partnership with Moderna will also strengthen our ability to respond to any future pandemics.

We are also told

Moderna worked closely with the Vaccine Taskforce during the pandemic,

The company has now committed to invest substantial funding in UK-based research and development activities,

over a 10-year period.

Perhaps, most concerning of all

This will include running a significant number of clinical trials in the UK

and it has also pledged to fund grants for UK universities,

including PhD places and research programmes.

Not mentioned in press release

Full explanation as to why the focus is exclusively on mRNA vaccines, rather than tired and tested traditional vaccines.

Why the UK government needs Moderna?

The partnership will issue guarantees that the funding will in no way influence the agenda of the employed scientists.